You are here

antitrust

Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust case

Fierce Pharma

Sun, 01/16/22 - 03:58 am

Shkreli's former company Vyera settles for $40M in antitrust case, but 'pharma bro' still faces his own trial

Fierce Pharma

Tue, 12/7/21 - 11:46 pm

Vyera Pharmaceuticals

Sun Pharma loses bid to drop Ranbaxy antitrust case; jury trail set for January

Fierce Pharma

Fri, 11/26/21 - 08:46 pm

Pfizer, Mylan escape another EpiPen lawsuit after judge scraps pharmacy chain's antitrust complaints

Fierce Pharma

Tue, 07/27/21 - 04:27 pm

Pfizer agrees to pay $345 mln to resolve EpiPen pricing lawsuit

Reuters

Fri, 07/16/21 - 11:07 am

Healthcare mergers, 'pay for delay' deals get added scrutiny under Biden order

BioPharma Dive

Sun, 07/11/21 - 10:55 pm

Pharma in the crosshairs: How the FTC is expanding its antitrust powers under its new chair

Endpoints

Fri, 07/2/21 - 11:08 am

Viatris scores a win in long-running EpiPen antitrust lawsuit, but patent settlement charge heads to trial

Fierce Pharma

Fri, 06/25/21 - 11:09 am

U.S. Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel drug

Yahoo/Reuters

Mon, 06/21/21 - 10:28 pm

Perrigo Company

'The lights are no longer green': Antitrust regulators reassess pharma deals

BioPharma Dive

Thu, 06/10/21 - 11:35 pm

Sanofi looks to take Mylan to court, again, over EpiPen antitrust allegations

Fierce Pharma

Wed, 06/2/21 - 12:14 pm

An antitrust expert weighs in on the FTC’s complaint against Illumina

Stat

Fri, 04/2/21 - 10:42 am

Antitrust Panel Sets Sights on Big Pharma for Next Target

BioSpace

Tue, 11/24/20 - 11:27 pm

Feds target Medtronic in ventilator antitrust investigation

Mass Device

Thu, 10/1/20 - 10:04 am

federal government

Novartis cancels $1B sale of generics after antitrust concerns forced delays

Endpoints

Thu, 04/2/20 - 10:49 am

Sandoz Pays $195 Million to Settle Criminal Antitrust Charges in Sweeping Federal Probe

BioSpace

Tue, 03/3/20 - 10:55 am

AbbVie nears Allergan lockup with EU antitrust approval—and only one selloff required

Fierce Pharma

Fri, 01/10/20 - 11:55 pm

Roche-Spark deal review in U.K. unnerves M&A watchers—and they were spooked already

Fierce Pharma

Wed, 09/25/19 - 11:57 am

Spark Therapeutics

FTC Issues Civil Investigative Demand to Johnson & Johnson Regarding Remicade

Big Molecule Watch

Sun, 08/25/19 - 05:02 pm

Wiping its slate ahead of BMS buy, Celgene to pay $117M in Revlimid antitrust settlements

Fierce Pharma

Fri, 08/2/19 - 12:28 am

Bristol-Myers Squibb

Pages